Recombinant Human SPINT1 protein (rFc Tag) (HPLC verified)
Species
Human
Purity
>90 %, SDS-PAGE
>90 %, SEC-HPLC
Tag
rFc Tag
Activity
not tested
Cat no : Eg3131
Validation Data Gallery
Product Information
Purity | >90 %, SDS-PAGE >90 %, SEC-HPLC |
Endotoxin | <0.1 EU/μg protein, LAL method |
Activity |
Not tested |
Expression | HEK293-derived Human SPINT1 protein Ala35-Glu465 (Accession# O43278-1) with a rabbit IgG Fc tag at the C-terminus. |
GeneID | 6692 |
Accession | O43278-1 |
PredictedSize | 73.8 kDa |
SDS-PAGE | 70-80 kDa, reducing (R) conditions |
Formulation | Lyophilized from 0.22 μm filtered solution in PBS, pH 7.4. Normally 5% trehalose and 5% mannitol are added as protectants before lyophilization. |
Reconstitution | Briefly centrifuge the tube before opening. Reconstitute at 0.1-0.5 mg/mL in sterile water. |
Storage Conditions |
It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
|
Shipping | The product is shipped at ambient temperature. Upon receipt, store it immediately at the recommended temperature. |
Background
SPINT1, or Serine Peptidase Inhibitor, Kunitz Type 1, is a protein encoded by the SPINT1 gene in humans. SPINT1 functions as a potent inhibitor specific for HGF activator and is thought to be involved in the regulation of the proteolytic activation of HGF in injured tissues. It has been shown to modulate HGF/MET activation in certain cancer types, suggesting its role in tumor biology (PMID: 29532159). Furthermore, SPINT1 has been implicated in glucose homeostasis and insulin production. Studies have shown that SPINT1 disruption in mouse pancreas leads to glucose intolerance and impaired insulin production, involving the HEPSIN/MAFA signaling pathway (PMID: 39627229).
References:
1. Liu CL. et al. (2018). Histochem Cell Biol. 149(6):635-644. 2. Lin HH. et al. (2024). Nat Commun. 15(1):10537.